Now, scientists think they have figured out how nelfinavir and other drugs work their double magic.

Then the team created an algorithm, based on the three-dimensional structure of nelfinavir, to search for the proteins to which the drug would bind.

Although these kinases have very different functions from HIV enzymes, their shapes are similar enough to allow nelfinavir to bind and disrupt their activity.